-
EP3331522
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3331522
| EP3331522 - METHODS FOR THE TREATMENT OF MAST CELL RELATED DISORDERS WITH MAST CELL STABILIZERS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 18.06.2021 Database last updated on 31.05.2024 | |
| Former | Examination is in progress Status updated on 07.05.2019 | ||
| Former | Request for examination was made Status updated on 11.05.2018 | ||
| Former | The international publication has been made Status updated on 18.02.2017 | Most recent event Tooltip | 18.06.2021 | Application deemed to be withdrawn | published on 21.07.2021 [2021/29] | Applicant(s) | For all designated states Respivant Sciences GmbH Viaduktstrasse 8 4051 Basel / CH | [2019/37] |
| Former [2018/24] | For all designated states Patara Pharma LLC 11455 El Camino Real Suite 460 San Diego, CA 92130 / US | Inventor(s) | 01 /
GERHART, William PO Box 1124 Del Mar, California 92014 / US | 02 /
SONI, Pravin 1320 Bedford Avenue Sunnyvale, California 94087 / US | 03 /
TUTUNCU, Ahmet 1807 Seaview Avenue Del Mar, California 92014 / US | [2018/24] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2018/24] | Application number, filing date | 16751790.3 | 05.08.2016 | [2018/24] | WO2016US45804 | Priority number, date | US201562202552P | 07.08.2015 Original published format: US 201562202552 P | [2018/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017027387 | Date: | 16.02.2017 | Language: | EN | [2017/07] | Type: | A1 Application with search report | No.: | EP3331522 | Date: | 13.06.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.02.2017 takes the place of the publication of the European patent application. | [2018/24] | Search report(s) | International search report - published on: | EP | 16.02.2017 | Classification | IPC: | A61K31/35, A61P37/08 | [2018/24] | CPC: |
A61K31/352 (EP,US);
A61K31/35 (EP,US);
A61K9/0078 (US);
A61P37/08 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/24] | Title | German: | VERFAHREN ZUR BEHANDLUNG VON MASTZELLBEDINGTEN ERKRANKUNGEN MIT MASTZELLSTABILISATOREN | [2018/24] | English: | METHODS FOR THE TREATMENT OF MAST CELL RELATED DISORDERS WITH MAST CELL STABILIZERS | [2018/24] | French: | MÉTHODES DE TRAITEMENT DE TROUBLES LIÉS AUX MASTOCYTES PAR DES STABILISATEURS DE MASTOCYTES | [2018/24] | Entry into regional phase | 07.03.2018 | National basic fee paid | 07.03.2018 | Designation fee(s) paid | 07.03.2018 | Examination fee paid | Examination procedure | 07.03.2018 | Examination requested [2018/24] | 07.03.2018 | Date on which the examining division has become responsible | 02.10.2018 | Amendment by applicant (claims and/or description) | 10.05.2019 | Despatch of a communication from the examining division (Time limit: M06) | 25.02.2020 | Reply to a communication from the examining division | 13.08.2020 | Despatch of a communication from the examining division (Time limit: M06) | 24.02.2021 | Application deemed to be withdrawn, date of legal effect [2021/29] | 17.03.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2021/29] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 25.02.2020 | Request for further processing filed | 25.02.2020 | Full payment received (date of receipt of payment) Request granted | 06.03.2020 | Decision despatched | Fees paid | Renewal fee | 28.08.2018 | Renewal fee patent year 03 | 27.08.2019 | Renewal fee patent year 04 | 27.08.2020 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [I]EP2248517 (PARI PHARMA GMBH [DE]) [I] 1-142 * paragraphs [0029] , [0 36]; claims 1, 6 *; | [AP]WO2015120389 (PATARA PHARMA LLC [US]) [AP] 1-142 * paragraph [0006]; claim 1 *; | [I] - ROBUSCHI M ET AL, "Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, AMERICAN LUNG ASSOCIATION, NEW YORK, NY, US, (19970401), vol. 155, no. 4, ISSN 1073-449X, pages 1461 - 1464, XP009191918 [I] 1-142 * page 1462, paragraph 2 * |